cytellin and Niemann-Pick-Disease--Type-C

cytellin has been researched along with Niemann-Pick-Disease--Type-C* in 1 studies

Other Studies

1 other study(ies) available for cytellin and Niemann-Pick-Disease--Type-C

ArticleYear
Dietary plant stanol ester supplementation reduces peripheral symptoms in a mouse model of Niemann-Pick type C1 disease.
    Journal of lipid research, 2020, Volume: 61, Issue:6

    Niemann-Pick type C (NPC)1 disease is a rare genetic condition in which the function of the lysosomal cholesterol transporter NPC1 protein is impaired. Consequently, sphingolipids and cholesterol accumulate in lysosomes of all tissues, triggering a cascade of pathological events that culminate in severe systemic and neurological symptoms. Lysosomal cholesterol accumulation is also a key factor in the development of atherosclerosis and NASH. In these two metabolic diseases, the administration of plant stanol esters has been shown to ameliorate cellular cholesterol accumulation and inflammation. Given the overlap of pathological mechanisms among atherosclerosis, NASH, and NPC1 disease, we sought to investigate whether dietary supplementation with plant stanol esters improves the peripheral features of NPC1 disease. To this end, we used an NPC1 murine model featuring a

    Topics: Animals; Cholesterol; Dietary Supplements; Disease Models, Animal; Liver; Male; Mice; Niemann-Pick Disease, Type C; Sitosterols; Sphingolipids

2020